We are supporting hospitals and payers that require a continuous remote monitoring system to manage their high-risk patients and clinicians.
We are supporting biopharma companies that require a launch-ready platform solution to support COVID-19 clinical trials as well as those that need to transition to virtual data collection.
Updates
-
AI-Powered physIQ Inks DOD Contract to Support COVID-19 Research
Polsky Center at the University of Chicago: The digital health company physIQ is using FDA-cleared artificial intelligence-based analytics to analyze data from COVID-19 patients and those at high risk of exposure.
-
Amid COVID-19 test shortages, Pentagon funds tech firm's push to identify infections with body-worn sensors
The effort comes as experts worry about a "second wave" of the pandemic.
-
PhysIQ, Department of Defense, and The Henry M. Jackson Foundation for The Advancement of Military Medicine Partner to Deploy Continuous Remote Monitoring Platform to Study COVID-19
The U.S. Department of Defense and the Henry Jackson Foundation for the Advancement of Military Medicine announced they have selected pinpointIQ, physIQ’s continuous remote monitoring solution, to study and treat COVID-19.
-
Four ways life sciences companies are adapting to a COVID-19 world
While many life sciences leaders have mitigated the most pressing short-term issues, many questions remain about the longer term strategic implications of this pandemic.